Skip to main content

Table 1 Baseline characteristics of the study cohort at the beginning of the follow up period

From: Individualized treatment with denosumab in children with osteogenesis imperfecta – follow up of a trial cohort

Participants [n] 10
Male [n] (%) 7 (70)
Age Mean [years] (range) 8.6 (6.16 – 12.13)
Height Mean [cm] (range) 110.1 (65.0 – 140.0)
Height Z-Scores ± SD -4.53 ± 4.36
Weight Mean [kg] (range) 24.8 (7.8 – 30.1)
BMI Mean [kg/m2] (SEM) 18.33 (13.1 – 34.4)
OI Type 1/4 [n] (%) 8 (80)
OI Type 1/4 able to walk (GMFM item 69) n (%) 7 (70)
OI Type 3 [n] (%) 2 (20)
OI Type 3 able to walk (GMFM item 69) n (%) 0 (0)
Causative gene
COL1A1 [n] (%) 7 (70)
COL1A2 [n] (%) 3 (30)